new_0222_0175|CERE|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0175|CERE|Long Name|1|1|Cerevel Therapeutics Holdings Inc Total Current Assets (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Cash and Short Term Investments (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Inventories (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Net PP&E (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Goodwill and Intangibles (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Liabilities (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Current Liabilities (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Long Term Liabilities (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Deposits (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Book Value (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Retained Earnings (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Treasury Stock (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc EV to Revenues|Cerevel Therapeutics Holdings Inc EV to Earnings|Cerevel Therapeutics Holdings Inc EV to Free Cash Flow|Cerevel Therapeutics Holdings Inc EV to Assets (Quarterly)|Cerevel Therapeutics Holdings Inc PS Ratio|Cerevel Therapeutics Holdings Inc PE Ratio|Cerevel Therapeutics Holdings Inc Price to Book Value|Cerevel Therapeutics Holdings Inc PEG Ratio|Cerevel Therapeutics Holdings Inc Debt to Equity Ratio|Cerevel Therapeutics Holdings Inc Dividend Yield|Cerevel Therapeutics Holdings Inc Shareholder Yield (TTM)|Cerevel Therapeutics Holdings Inc Percent of Shares Outstanding Short|Cerevel Therapeutics Holdings Inc Total Receivables (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Payables (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Total Capital Stock (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Return on Invested Capital|Cerevel Therapeutics Holdings Inc Quality Ratio Score|Cerevel Therapeutics Holdings Inc Momentum Score|Cerevel Therapeutics Holdings Inc Beta (1Y)|Cerevel Therapeutics Holdings Inc Sustainable Growth Rate (TTM)|Cerevel Therapeutics Holdings Inc Institutional Investor Ownership Percentage|Cerevel Therapeutics Holdings Inc Average Diluted Shares Outstanding (Quarterly)|Cerevel Therapeutics Holdings Inc Total Employees (Annual)|Cerevel Therapeutics Holdings Inc EPS Diluted (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Shares Outstanding|Cerevel Therapeutics Holdings Inc Repurchase of Capital Stock (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Ordinary Shares Number (Quarterly)|Cerevel Therapeutics Holdings Inc Payout Ratio|Cerevel Therapeutics Holdings Inc Quick Ratio (Quarterly)|Cerevel Therapeutics Holdings Inc Normalized Diluted EPS (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Stock Buybacks (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Effective Tax Rate (TTM)|Cerevel Therapeutics Holdings Inc Return on Equity|Cerevel Therapeutics Holdings Inc Net Income (TTM) (USD)|Cerevel Therapeutics Holdings Inc Revenue (TTM) (USD)|Cerevel Therapeutics Holdings Inc Dividend Per Share (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Revenue (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Gross Profit (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc SG&A Expense (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Pre-Tax Income (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Net Income (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Net Interest Income (Quarterly) (USD)|Cerevel Therapeutics Holdings Inc Price (USD)|Cerevel Therapeutics Holdings Inc Total Return Price (USD)|Cerevel Therapeutics Holdings Inc Enterprise Value (USD)|Cerevel Therapeutics Holdings Inc 30-Day Average Daily Volume|Cerevel Therapeutics Holdings Inc 1 Year Price Returns (Daily)
new_0222_0175|CERE|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0175|CERE||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0175|CERE||5|5|91.25|91.25|0|91|0|91.25|91.25|91.25|0|91.25|91.25|0|0|0|1.44912280702|0|0|0|1.44848484848|0|0|1.44984802432|0|15.2666666667|0|91.25|91.25|0|0|31|30.6666666667|0|30.2|91.3333333333|273|91.3333333333|33.9090909091|0|91.25|0|0|91.3333333333|91.25|91|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.44848484848|1.44848484848|1.44984802432|1.45|1.45454545455
new_0222_0175|CERE||6|6|4|4|0|3|0|4|4|4|0|4|4|0|0|0|285|0|0|0|330|0|0|329|0|30|0|4|4|0|0|2|3|0|5|6|1|6|11|0|4|0|0|6|4|3|0|3|0|0|0|0|6|6|6|6|330|330|329|300|77
new_0222_0175|CERE||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0175|CERE|202003|202003|202003||||||||||||||||||||||||||||||||||127.124||-0.4186||||||-0.4186|||||||||10.743|-53.208|-53.208|0.204|||||
new_0222_0175|CERE|202006|202006|202006||||||||||||||||||||||||||||||||||127.124||-0.2102||||||-0.2102|||||||||12.973|-26.733|-26.717|0.005|||||
new_0222_0175|CERE|202009|202009|202009|0.9492|0.6094||||7.9295|2.697|5.2325||142.5903|-3.1242|||||||||||||||0.1518|137.5908|||||||127.124||-0.3071|||127.124|||-0.3071|0||||||||10.336|-39.045|-39.04|0.001|||||
new_0222_0175|CERE|202010|202009|202009|||||||||||||||||||9.1828|||0||0.0289|||||||||||||127.124||||||||||||||||||10.3|10.3|1308.7678||
new_0222_0175|CERE|202011|202009|202009|||||||||||||||||||12.5884|||0||0.1359|||||||||3.7427||||127.124||||||||||||||||||14.12|14.12|1794.3815||
new_0222_0175|CERE|202012|202012|202012|390.56|383.623||48.624||60.753|29.548|31.205||384.52|-390.91||||-12.6128||||5.4814|||0||1.9234||4.993|0.013||||||83.0262|127.124|104|-0.27|127.124||127.124|||-0.27|0|0.0158||-152.142|||||11.761|-33.18|-33.177|0.014|16.58|16.58|1724.0929|588418.7667|
new_0222_0175|CERE|202101|202012|202012|||||||||||||||-9.1625||||4.2549|||0||1.1852|||||||||82.9967||||||||||||||||||||||12.87|12.87|1252.4629|463482.3667|
new_0222_0175|CERE|202102|202012|202012|||||||||||||||-11.2922||||5.012|||0||1.8679|||||||||83.6981||||||||||||||||||||||15.16|15.16|1543.5768|251361.6667|
new_0222_0175|CERE|202103|202103|202103|349.811|343.287||51.784||68.068|34.151|33.917||340.036|-441.891||||-9.6382||||5.1411|||0||2.9158||7.755|0.013||||||99.7314|127.2255||-0.4|127.3251||127.3251|||-0.4||0.016||-149.915|||||14.01|-50.981|-50.981|0.015|13.73|13.73|1404.8866|251775.7|
new_0222_0175|CERE|202104|202103|202103|||||||||||||||-10.3661||||5.4532|||0||3.2709|||||||||99.814||||127.4415||||||||||||||||||14.55|14.55|1510.9868|259478.4|
new_0222_0175|CERE|202105|202103|202103|||||||||||||||-9.1174||||4.9179|||0||3.3198|||||||||||||127.4591||||||||||||||||||13.12|13.12|1328.9764|212915.3|
new_0222_0175|CERE|202106|202106|202106|331.782|327.06||51.92||97.117|29.257|67.86||293.887|-495.13||||-17.6249||||11.1224|||0||3.6144||4.986|0.013|||||||127.4821||-0.42|127.5847||127.5847|||-0.42||0.0045||-176.437|||||13.216|-53.239|-53.239|0.01|25.62|25.62|2941.66|3512834.6|
new_0222_0175|CERE|202107|202106|202106|||||||||||||||-18.924||||11.8602|||0||3.0675|||||||||||||141.4591||||||||||||||||||24.64|24.64|3158.4922|4450690.7667|
new_0222_0175|CERE|202108|202106|202106|||||||||||||||-25.5208||||15.6066|||0||2.8515|||||||||||||144.8698||||||||||||||||||31.66|31.66|4259.5179|614523.0333|
new_0222_0175|CERE|202109|202109|202109|675.029|669.676||51.98||104.4|30.8|73.6||629.08|-557.189||||-19.8975||||6.8998|||0||3.0585||5.445|0.015|||||||144.0221|168|-0.43|147.136||147.136|||-0.43|-328.251|0.0015||-199.456|||||14.368|-62.059|-62.059|0.013|29.5|29.5|3670.836|594887.1667|
new_0222_0175|CERE|202110|202109|202109|||||||||||||||-28.7901||||9.5077|||0||2.8276|||||||3.2479||||||||||||||||||||||||40.65|40.65|5311.4024|422677.6667|306.5
new_0222_0175|CERE|202111|202109|202109|||||||||||||||-21.2622||||7.3|||0||2.1777||||||10|4.2613||||||147.2358||||||||||||||||||31.19|31.19|3922.6086|361889.2333|120.8924
new_0222_0175|CERE|202112|202112|202112|||||||||||||||-22.2439||||7.5879|||0||2.3696||||||9|3.9238||||||||||||||||||||||||32.42|32.42|4103.7086|430692.7667|95.5368
new_0222_0175|CERE|202201|202112|202112|||||||||||||||-17.1521||||6.0946|||0||2.2839||||||9|3.5828||||||||||||||||||||||||26.04|26.04|3164.3442|453357.5333|102.331
new_0222_0175|CERE|202202|202112|202112|||||||||||||||-16.9207||||5.4499|||0|||||||||||||||||||||||||||||||||23.285|23.285|3121.6459|525596.2333|72.8188